Home
Conditions
Advanced Hepatocellular Carcinoma (HCC)

Clinical trial condition

Advanced Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Advanced Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

20 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Advanced Hepatocellular Carcinoma (HCC) trial results

Recruiting

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

NCT06737913

Conditions: Advanced Hepatocellular Carcinoma (HCC)
Locations: Gansu Province Cancer Hospital Lanzhou, Gansu, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma

NCT07493044

Conditions: Adenocarcinoma, Advanced Hepatocellular Carcinoma (HCC), Carcinoma, +10 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Gaungdong, China

View Trial Details

Recruiting

Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment

NCT07147101

Conditions: Advanced Hepatocellular Carcinoma (HCC)
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC

NCT07500220

Conditions: Advanced Hepatocellular Carcinoma (HCC), Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

Phase 2 Study of WGI-0301 for Advanced HCC

NCT06309485

Conditions: Advanced Hepatocellular Carcinoma (HCC)
Locations: China Pharmaceutical University, Shanghai Gobroad Cancer Hospital Shanghai, Shanghai Municipality, China

West China Hospital Sichuan University Chengdu, China

Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou, China

Prince of Wales Hospital Hong Kong

View Trial Details

Recruiting

A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)

NCT07039201

Conditions: Advanced Hepatocellular Carcinoma (HCC)
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

First Affiliated Hospital, Medical College of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion

NCT06828380

Conditions: Advanced Hepatocellular Carcinoma (HCC)
Locations: National Cancer Center Goyang, South Korea

Samsung Medical Center, Seoul Seoul, South Korea

View Trial Details

Recruiting

A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

NCT06902389

Conditions: Advanced Hepatocellular Carcinoma (HCC)
Locations: The Third Affiliated Hospital of Navy Military Medical University Shanghai, Yangpu District, China

View Trial Details

Recruiting

Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma

NCT07123545

Conditions: Advanced Hepatocellular Carcinoma (HCC)
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma

NCT06995105

Conditions: Advanced Hepatocellular Carcinoma (HCC)
Locations: the First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma (HCC) trial results

Related conditions